Terms: = Lung cancer AND ATR, Q13535, 545, ENSG00000175054, MEC1, SCKL, SCKL1, FRP1 AND Clinical Outcome
5 results:
1. clinical and Imaging Characteristics of SARS-CoV-2 Breakthrough Infection in Hospitalized Immunocompromised Patients.
Lee JE; Kim J; Hwang M; Kim YH; Chung MJ; Jeong WG; Jeong YJ
Korean J Radiol; 2024 May; 25(5):481-492. PubMed ID: 38627873
[TBL] [Abstract] [Full Text] [Related]
2. Tumor immune microenvironment predicts the pathologic response of neoadjuvant chemoimmunotherapy in non-small-cell lung cancer.
Han R; Zhang Y; Wang T; Xiao H; Luo Z; Shen C; Li J; Zhao C; Li L; Zhu M; Du H; Tang H; Ma Z; Wang Y; He Y
Cancer Sci; 2023 Jun; 114(6):2569-2583. PubMed ID: 36880750
[TBL] [Abstract] [Full Text] [Related]
3. Tumor spread through air spaces is a useful predictor of recurrence and prognosis in stage I lung squamous cell carcinoma, but not in stage II and III.
Yanagawa N; Shiono S; Endo M; Ogata SY
Lung Cancer; 2018 Jun; 120():14-21. PubMed ID: 29748009
[TBL] [Abstract] [Full Text] [Related]
4. ATM protein is deficient in over 40% of lung adenocarcinomas.
Villaruz LC; Jones H; Dacic S; Abberbock S; Kurland BF; Stabile LP; Siegfried JM; Conrads TP; Smith NR; O'Connor MJ; Pierce AJ; Bakkenist CJ
Oncotarget; 2016 Sep; 7(36):57714-57725. PubMed ID: 27259260
[TBL] [Abstract] [Full Text] [Related]
5. Polymorphism within the cyclin D1 gene is associated with prognosis in patients with squamous cell carcinoma of the head and neck.
Matthias C; Branigan K; Jahnke V; Leder K; Haas J; Heighway J; Jones PW; Strange RC; Fryer AA; Hoban PR
Clin Cancer Res; 1998 Oct; 4(10):2411-8. PubMed ID: 9796972
[TBL] [Abstract] [Full Text] [Related]
